Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederpubmed.ncbi.nlm.nih.gov
Durva OR Treme OR Pembrolizumab OR nivolumab OR atezolizumab OR sasanlimab OR tarlatamab AND lung cancer AND 2025:2025[pdat] AND 2025:2025[pdat]
Get the latest updates from Durva OR Treme OR Pembrolizumab OR nivolumab OR atezolizumab OR sasanlimab OR tarlatamab AND lung cancer AND 2025:2025[pdat] AND 2025:2025[pdat] directly as they happen.
Follow now 168 followers
Latest posts
Last updated about 6 hours ago
Phase III study of ramucirumab plus docetaxel versus atezolizumab for previously treated PD-L1 low or negative advanced non-small-cell lung cancer: WJOG10317L study
1 day ago
Lung Cancer. 2025 Jun 23;206:108633. doi: 10.1016/j.lungcan.2025.108633. Online ahead of print.ABSTRACTPURPOSE: We...
Impact of antiemetic steroid use on survival in small cell lung cancer patients receiving immune checkpoint inhibitors and chemotherapy
1 day ago
Sci Rep. 2025 Jul 1;15(1):22108. doi: 10.1038/s41598-025-05899-w.ABSTRACTImmune checkpoint inhibitors (ICIs) combined with...
The Role of Axl Inhibition and Immune Checkpoint Blockade in Non-small Cell Lung Cancer: Current Understanding and Treatment Strategies
1 day ago
Cancer Diagn Progn. 2025 Jun 30;5(4):417-428. doi: 10.21873/cdp.10455. eCollection 2025 Jul-Aug.ABSTRACTNon-small cell...
Effect and safety of immune checkpoint inhibitors in metastatic lung cancer: A retrospective study
1 day ago
Bioinformation. 2025 Mar 31;21(3):534-537. doi: 10.6026/973206300210534. eCollection 2025.ABSTRACTCancer is a major global...
The effectiveness of pembrolizumab maintenance with or without pemetrexed after induction treatment for advanced non-squamous Non-Small-Cell Lung cancer
2 days ago
Lung Cancer. 2025 Jun 27;206:108642. doi: 10.1016/j.lungcan.2025.108642. Online ahead of print.ABSTRACTINTRODUCTION: The...
Evaluating Tumor Dynamics Using Circulating Tumor DNA in the Rare Cancer Anorectal Malignant Melanoma: A Report of Two Cases
2 days ago
Surg Case Rep. 2025;11(1):25-0109. doi: 10.70352/scrj.cr.25-0109. Epub 2025 Jun 17.ABSTRACTINTRODUCTION: Anorectal malignant...
Steroid resistant bullous pemphigoid induced by pembrolizumab in a patient with metastatic lung adenocarcinoma: case report and review of the literature
2 days ago
Discov Oncol. 2025 Jul 1;16(1):1195. doi: 10.1007/s12672-025-02377-7.ABSTRACTBACKGROUND: Pembrolizumab, a PD-1 inhibitor, is...
Literature case analysis of immune checkpoint inhibitors-associated lipodystrophy
2 days ago
Melanoma Res. 2025 Jul 1. doi: 10.1097/CMR.0000000000001053. Online ahead of print.ABSTRACTTo investigate...
Phase II basket trial of Dual Anti-CTLA-4 and anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609: pancreatic neuroendocrine neoplasm (PNEN) cohort
3 days ago
J Immunother Cancer. 2025 Jun 30;13(6):e011760. doi: 10.1136/jitc-2025-011760.ABSTRACTPURPOSE: SWOG S1609 Dual Anti-CTLA-4...
Clinical Outcomes of Perioperative Immunotherapy in Resectable Non-Small Cell Lung Cancer
3 days ago
JAMA Netw Open. 2025 Jun 2;8(6):e2517953. doi: 10.1001/jamanetworkopen.2025.17953.ABSTRACTIMPORTANCE: Lung cancer remains a...
The therapeutic potential for JAK inhibitors for immune-related adverse events from checkpoint inhibitors- a review of the literature
3 days ago
Rheumatology (Oxford). 2025 Jun 30:keaf356. doi: 10.1093/rheumatology/keaf356. Online ahead of print.ABSTRACTOBJECTIVES: The...
Prophylactic Interventions to Prevent Severe Skin Toxicities in Patients With Non-Small Cell Lung Cancer Treated With Nivolumab + Ipilimumab With or Without Chemotherapy
3 days ago
JCO Oncol Pract. 2025 Jun 30:OP2500100. doi: 10.1200/OP-25-00100. Online ahead of print.ABSTRACTPURPOSE...